AUSTRALIAN medtech company, MedAdvisor, has announced the completion of its $49 million acquisition of US-based Adheris Health (PD 02 Nov).
The deal is set to deliver "immediate scale" in the US market, making the business a leader in tailored opt-out medication adherence programs with "an addressable network of 180 million patients, approximately 25,000 pharmacies and 618,000 prescribers".
MedAdvisor CEO, Robert Read, said the company was "thrilled" to complete the transaction, which received strong support from institutional investors.
"Our focus now is to transition into execution mode - leveraging a strong pipeline of deals to accelerate MedAdvisor's growth in the US through the Adheris Health network," he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 20
